H.C. Wainwright Reaffirms Their Buy Rating on 4D Molecular Therapeutics (FDMT)
In a report released today, Matthew Caufield from H.C. Wainwright reiterated a Buy rating on 4D Molecular Therapeutics (FDMT – Research ...
Le Lézard4d
Nanoscope Therapeutics to Present at the 21st Annual Advanced Therapies Week Conference
Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in real-world settings by developing and commercializing novel gene therapies for retinal ...